According to Kaplan-Meier plotter, we found that a higher FSCN1 expression was positively correlated with overall and progression-free survival rates of all cancer patients, even stratified by gender, TNM staging, lymph node involvement, any treatment (i.e. surgery alone, 5-FU-base adjuvant and other), Lauren's classification and Her2 expression (Figure 4B and Table 2, p<0.05). Here, FSCN1 is linked to cancer.